Concepedia

Masashi Shimura

MS

Statistics

Publications

8

Citations

201

H-Index

8

Active since

2009

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Kanagawa Cancer Center

Kanagawa Prefectural Hospital Organization

University of Tsukuba

Chiba Cancer Center

Masashi Shimura is an author at Taiho Pharmaceutical (Japan) specializing in medicine, oncology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2009–2024

8

Publications

8

Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial

Atsuo Takashima, Kohei Shitara, Kazumasa Fujitani et al. · Gastric Cancer · 2018 · 48 citations · Full text

The effect of geometry of the tibial polyethylene insert on the tibiofemoral contact kinematics in Advance Medial Pivot total knee arthroplasty

Go Omori, N. Onda, Masashi Shimura et al. · Journal of Orthopaedic Science · 2009 · 41 citations

, , +7

Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies

Mitsuru Takahashi, Shunji Takahashi, Nobuhito Araki et al. · The Oncologist · 2017 · 30 citations · Full text

Practical characteristics of adaptive design in phase 2 and 3 clinical trials

Akira Sato, Masashi Shimura, Masahiko Gosho · Journal of Clinical Pharmacy and Therapeutics · 2017 · 26 citations

Futibatinib plus pembrolizumab in patients (pts) with advanced or metastatic urothelial carcinoma (mUC): Preliminary safety results from a phase 2 study.

Vadim S. Koshkin, Guru Sonpavde, Clara Hwang et al. · Journal of Clinical Oncology · 2022 · 19 citations

, , +20

1–5 of 8